COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
2seventy bio, Inc. | COMMON STOCK | 901384107 | 35,190 | 2,062,744 | SH | | SOLE | | 2,062,744 | 0 | 0 |
AbCellera Biologics Inc. | COM | 00288U106 | 101,889 | 10,450,180 | SH | | SOLE | | 10,450,180 | 0 | 0 |
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 1,015,077 | 41,910,704 | SH | | SOLE | | 41,910,704 | 0 | 0 |
Achilles Therapeutics plc | SPONSORED ADS | 00449L102 | 7,619 | 2,591,366 | SH | | SOLE | | 2,591,366 | 0 | 0 |
Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | 20,252 | 9,830,877 | SH | | SOLE | | 9,830,877 | 0 | 0 |
Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 7,843 | 3,410,106 | SH | | SOLE | | 3,410,106 | 0 | 0 |
Aerovate Therapeutics, Inc. | COM | 008064107 | 37,943 | 2,070,010 | SH | | SOLE | | 2,070,010 | 0 | 0 |
Affimed N.V. | COM | N01045108 | 22,519 | 5,153,169 | SH | | SOLE | | 5,153,169 | 0 | 0 |
Akero Therapeutics, Inc. | COM | 00973Y108 | 1,680 | 118,378 | SH | | SOLE | | 118,378 | 0 | 0 |
Alector, Inc. | COM | 014442107 | 3,409 | 239,228 | SH | | SOLE | | 239,228 | 0 | 0 |
Aligos Therapeutics, Inc. | COM | 01626L105 | 4,464 | 2,076,400 | SH | | SOLE | | 2,076,400 | 0 | 0 |
Alkermes plc | SHS | G01767105 | 39,465 | 1,500,000 | SH | | SOLE | | 1,500,000 | 0 | 0 |
Allakos Inc. | COM | 01671P100 | 4,007 | 703,050 | SH | | SOLE | | 703,050 | 0 | 0 |
Altimmune, Inc. | COM | 02155H200 | 6,529 | 1,072,038 | SH | | SOLE | | 1,072,038 | 0 | 0 |
Amarin Corporation plc | SPONSORED ADR | 023111206 | 69,649 | 21,169,805 | SH | | SOLE | | 21,169,805 | 0 | 0 |
AnaptysBio, Inc. | COM | 032724106 | 10,568 | 427,179 | SH | | SOLE | | 427,179 | 0 | 0 |
argenx SE | SPONSORED ADR | 04016X101 | 353,008 | 1,119,557 | SH | | SOLE | | 1,119,557 | 0 | 0 |
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 533,003 | 4,541,604 | SH | | SOLE | | 4,541,604 | 0 | 0 |
Athira Pharma, Inc. | COM | 04746L104 | 10,886 | 806,367 | SH | | SOLE | | 806,367 | 0 | 0 |
Atreca, Inc. | CL A COM | 04965G109 | 11,199 | 3,532,760 | SH | | SOLE | | 3,532,760 | 0 | 0 |
aTyr Pharma, Inc. | COM | 002120202 | 3,344 | 625,000 | SH | | SOLE | | 625,000 | 0 | 0 |
Axsome Therapeutics, Inc. | COM | 05464T104 | 25,288 | 610,970 | SH | | SOLE | | 610,970 | 0 | 0 |
BeiGene, Ltd. | SPONSORED ADR | 07725L102 | 2,200,754 | 11,668,897 | SH | | SOLE | | 11,668,897 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | COM | 079481404 | 538 | 249,123 | SH | | SOLE | | 249,123 | 0 | 0 |
BioAtla, Inc. | COM | 09077B104 | 4,125 | 825,000 | SH | | SOLE | | 825,000 | 0 | 0 |
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 206,678 | 12,710,818 | SH | | SOLE | | 12,710,818 | 0 | 0 |
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 587,540 | 7,620,494 | SH | | SOLE | | 7,620,494 | 0 | 0 |
Biomea Fusion, Inc. | COM | 09077A106 | 6,919 | 1,551,445 | SH | | SOLE | | 1,551,445 | 0 | 0 |
bluebird bio, Inc. | COM | 09609G100 | 12,124 | 2,499,715 | SH | | SOLE | | 2,499,715 | 0 | 0 |
Burning Rock Biotech Limited | SPONSORED ADS | 12233L107 | 1,943 | 209,131 | SH | | SOLE | | 209,131 | 0 | 0 |
Cabaletta Bio, Inc. | COM | 12674W109 | 1,344 | 662,063 | SH | | SOLE | | 662,063 | 0 | 0 |
Centessa Pharmaceuticals plc | SPONSORED ADS | 152309100 | 10,112 | 1,127,273 | SH | | SOLE | | 1,127,273 | 0 | 0 |
Cerus Corporation | COM | 157085101 | 75,285 | 13,713,195 | SH | | SOLE | | 13,713,195 | 0 | 0 |
ChemoCentryx, Inc. | COM | 16383L106 | 22,986 | 916,862 | SH | | SOLE | | 916,862 | 0 | 0 |
Chinook Therapeutics, Inc. | COM | 16961L106 | 38,186 | 2,334,102 | SH | | SOLE | | 2,334,102 | 0 | 0 |
Crinetics Pharmaceuticals, Inc. | COM | 22663K107 | 18,163 | 827,480 | SH | | SOLE | | 827,480 | 0 | 0 |
CymaBay Therapeutics, Inc. | COM | 23257D103 | 6,750 | 2,170,464 | SH | | SOLE | | 2,170,464 | 0 | 0 |
Cyteir Therapeutics, Inc. | COM | 23284P103 | 3,064 | 812,640 | SH | | SOLE | | 812,640 | 0 | 0 |
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 23,237 | 14,614,264 | SH | | SOLE | | 14,614,264 | 0 | 0 |
Denali Therapeutics Inc. | COM | 24823R105 | 2,855 | 88,738 | SH | | SOLE | | 88,738 | 0 | 0 |
Design Therapeutics, Inc. | COM | 25056L103 | 23,202 | 1,436,636 | SH | | SOLE | | 1,436,636 | 0 | 0 |
DICE Therapeutics, Inc. | COM | 23345J104 | 11,253 | 588,235 | SH | | SOLE | | 588,235 | 0 | 0 |
Edgewise Therapeutics, Inc. | COM | 28036F105 | 4,850 | 500,000 | SH | | SOLE | | 500,000 | 0 | 0 |
Entrada Therapeutics, Inc. | COM | 29384C108 | 44,174 | 4,704,419 | SH | | SOLE | | 4,704,419 | 0 | 0 |
Epizyme, Inc. | COM | 29428V104 | 1,150 | 1,000,000 | SH | | SOLE | | 1,000,000 | 0 | 0 |
FibroGen, Inc. | COM | 31572Q808 | 6,993 | 581,750 | SH | | SOLE | | 581,750 | 0 | 0 |
Foghorn Therapeutics Inc. | COM | 344174107 | 686 | 45,027 | SH | | SOLE | | 45,027 | 0 | 0 |
Forma Therapeutics Holdings, Inc. | SHS | 34633R104 | 18,831 | 2,024,876 | SH | | SOLE | | 2,024,876 | 0 | 0 |
Fulgent Genetics, Inc. | COM | 359664109 | 12,572 | 201,444 | SH | | SOLE | | 201,444 | 0 | 0 |
Genetron Holdings Limited | ADS | 37186H100 | 997 | 455,306 | SH | | SOLE | | 455,306 | 0 | 0 |
Global Blood Therapeutics, Inc. | COM | 37890U108 | 114,823 | 3,314,765 | SH | | SOLE | | 3,314,765 | 0 | 0 |
Harmony Biosciences Holdings, Inc. | COM | 413197104 | 6,013 | 123,600 | SH | | SOLE | | 123,600 | 0 | 0 |
Heron Therapeutics, Inc. | COM | 427746102 | 46,513 | 8,131,678 | SH | | SOLE | | 8,131,678 | 0 | 0 |
HOOKIPA Pharma Inc. | COM | 43906K100 | 5,473 | 2,400,481 | SH | | SOLE | | 2,400,481 | 0 | 0 |
Horizon Therapeutics Public Ltd Co | SHS | G46188101 | 94,567 | 898,842 | SH | | SOLE | | 898,842 | 0 | 0 |
IGM Biosciences, Inc. | COM | 449585108 | 84,363 | 3,156,102 | SH | | SOLE | | 3,156,102 | 0 | 0 |
Immatics N.V. | SHS | N44445109 | 35,346 | 4,423,731 | SH | | SOLE | | 4,423,731 | 0 | 0 |
Immunocore Holdings plc | ADS | 45258D105 | 75,370 | 2,520,730 | SH | | SOLE | | 2,520,730 | 0 | 0 |
Incyte Corporation | COM | 45337C102 | 2,871,326 | 36,153,684 | SH | | SOLE | | 36,153,684 | 0 | 0 |
Inozyme Pharma, Inc. | COM | 45790W108 | 438 | 106,999 | SH | | SOLE | | 106,999 | 0 | 0 |
Insmed Incorporated | COM PAR $.01 | 457669307 | 50,666 | 2,156,001 | SH | | SOLE | | 2,156,001 | 0 | 0 |
Instil Bio, Inc. | COM | 45783C101 | 41,857 | 3,893,700 | SH | | SOLE | | 3,893,700 | 0 | 0 |
Invitae Corporation | COM | 46185L103 | 78,692 | 9,873,488 | SH | | SOLE | | 9,873,488 | 0 | 0 |
Iteos Therapeutics, Inc. | COM | 46565G104 | 4,838 | 150,346 | SH | | SOLE | | 150,346 | 0 | 0 |
Karuna Therapeutics, Inc. | COM | 48576A100 | 8,871 | 69,966 | SH | | SOLE | | 69,966 | 0 | 0 |
Kezar Life Sciences, Inc. | COM | 49372L100 | 2,321 | 139,676 | SH | | SOLE | | 139,676 | 0 | 0 |
Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | 27,828 | 2,799,577 | SH | | SOLE | | 2,799,577 | 0 | 0 |
Kodiak Sciences Inc. | COM | 50015M109 | 122,988 | 15,931,045 | SH | | SOLE | | 15,931,045 | 0 | 0 |
Krystal Biotech, Inc. | COM | 501147102 | 53,747 | 807,735 | SH | | SOLE | | 807,735 | 0 | 0 |
Kura Oncology, Inc. | COM | 50127T109 | 4,413 | 274,458 | SH | | SOLE | | 274,458 | 0 | 0 |
Kymera Therapeutics, Inc. | COM | 501575104 | 100,922 | 2,384,742 | SH | | SOLE | | 2,384,742 | 0 | 0 |
Leap Therapeutics, Inc. | COM | 52187K101 | 979 | 559,705 | SH | | SOLE | | 559,705 | 0 | 0 |
Legend Biotech Corporation | SPONSORED ADS | 52490G102 | 73,007 | 2,008,999 | SH | | SOLE | | 2,008,999 | 0 | 0 |
LogicBio Therapeutics, Inc. | COM | 54142F102 | 307 | 451,478 | SH | | SOLE | | 451,478 | 0 | 0 |
MacroGenics, Inc. | COM | 556099109 | 3,899 | 442,579 | SH | | SOLE | | 442,579 | 0 | 0 |
Madrigal Pharmaceuticals, Inc. | COM | 558868105 | 147,103 | 1,499,213 | SH | | SOLE | | 1,499,213 | 0 | 0 |
Merus N.V. | COM | N5749R100 | 53,871 | 2,037,469 | SH | | SOLE | | 2,037,469 | 0 | 0 |
Mirati Therapeutics, Inc. | COM | 60468T105 | 115,912 | 1,409,784 | SH | | SOLE | | 1,409,784 | 0 | 0 |
Neoleukin Therapeutics, Inc. | COM | 64049K104 | 7,185 | 3,821,740 | SH | | SOLE | | 3,821,740 | 0 | 0 |
Neurocrine Biosciences, Inc. | COM | 64125C109 | 63,466 | 676,975 | SH | | SOLE | | 676,975 | 0 | 0 |
NexImmune, Inc. | COM | 65344D109 | 1,238 | 294,117 | SH | | SOLE | | 294,117 | 0 | 0 |
NGM Biopharmaceuticals, Inc. | COM | 62921N105 | 4,450 | 291,801 | SH | | SOLE | | 291,801 | 0 | 0 |
Novavax, Inc. | COM | 670002401 | 3,548 | 48,168 | SH | | SOLE | | 48,168 | 0 | 0 |
Nurix Therapeutics, Inc. | COM | 67080M103 | 34,382 | 2,454,082 | SH | | SOLE | | 2,454,082 | 0 | 0 |
Opthea Limited | SPONSORED ADS | 68386J208 | 18,485 | 2,696,191 | SH | | SOLE | | 2,696,191 | 0 | 0 |
Otonomy, Inc. | COM | 68906L105 | 18,827 | 7,844,692 | SH | | SOLE | | 7,844,692 | 0 | 0 |
Oyster Point Pharma, Inc. | COM | 69242L106 | 715 | 61,424 | SH | | SOLE | | 61,424 | 0 | 0 |
Pacific Biosciences of California, Inc. | COM | 69404D108 | 49,549 | 5,444,963 | SH | | SOLE | | 5,444,963 | 0 | 0 |
Passage Bio, Inc. | COM | 702712100 | 363 | 117,161 | SH | | SOLE | | 117,161 | 0 | 0 |
Prelude Therapeutics Inc. | COM | 74065P101 | 69,854 | 10,123,824 | SH | | SOLE | | 10,123,824 | 0 | 0 |
Protara Therapeutics, Inc. | COM STK | 74365U107 | 1,020 | 199,671 | SH | | SOLE | | 199,671 | 0 | 0 |
Reata Pharmaceuticals, Inc. | CL A | 75615P103 | 7,337 | 223,976 | SH | | SOLE | | 223,976 | 0 | 0 |
Relmada Therapeutics, Inc. | COM | 75955J402 | 13,363 | 495,113 | SH | | SOLE | | 495,113 | 0 | 0 |
Replimune Group, Inc. | COM | 76029N106 | 27,367 | 1,611,703 | SH | | SOLE | | 1,611,703 | 0 | 0 |
Revolution Medicines, Inc. | COM | 76155X100 | 5,669 | 222,222 | SH | | SOLE | | 222,222 | 0 | 0 |
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 47,521 | 4,125,062 | SH | | SOLE | | 4,125,062 | 0 | 0 |
Sarepta Therapeutics, Inc. | COM | 803607100 | 9,644 | 123,456 | SH | | SOLE | | 123,456 | 0 | 0 |
Seagen Inc. | COM | 81181C104 | 6,757,712 | 46,912,266 | SH | | SOLE | | 46,912,266 | 0 | 0 |
Sera Prognostics, Inc. | CLASS A COM | 81749D107 | 764 | 201,562 | SH | | SOLE | | 201,562 | 0 | 0 |
Surrozen, Inc. | COM | 86889P109 | 7,525 | 2,500,000 | SH | | SOLE | | 2,500,000 | 0 | 0 |
Surrozen, Inc. | W EXP 8/11/2026 | 86889P117 | 208 | 833,333 | SH | | SOLE | | 833,333 | 0 | 0 |
Syndax Pharmaceuticals, Inc. | COM | 87164F105 | 1,924 | 110,729 | SH | | SOLE | | 110,729 | 0 | 0 |
Talis Biomedical Corporation | COM | 87424L108 | 10,751 | 7,624,835 | SH | | SOLE | | 7,624,835 | 0 | 0 |
Tango Therapeutics, Inc. | COM | 87583X109 | 5,685 | 750,000 | SH | | SOLE | | 750,000 | 0 | 0 |
TCR2 Therapeutics Inc. | COM | 87808K106 | 2,078 | 753,064 | SH | | SOLE | | 753,064 | 0 | 0 |
Travere Therapeutics, Inc. | COM | 89422G107 | 85,041 | 3,300,009 | SH | | SOLE | | 3,300,009 | 0 | 0 |
Tricida, Inc. | COM | 89610F101 | 14,235 | 1,731,714 | SH | | SOLE | | 1,731,714 | 0 | 0 |
TScan Therapeutics, Inc. | COM | 89854M101 | 3,990 | 1,425,000 | SH | | SOLE | | 1,425,000 | 0 | 0 |
Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | 32,276 | 444,444 | SH | | SOLE | | 444,444 | 0 | 0 |
Vera Therapeutics, Inc. | CL A | 92337R101 | 7,830 | 333,333 | SH | | SOLE | | 333,333 | 0 | 0 |
Verastem, Inc. | COM | 92337C104 | 38,054 | 26,988,898 | SH | | SOLE | | 26,988,898 | 0 | 0 |
Verve Therapeutics, Inc. | COM | 92539P101 | 32,325 | 1,416,530 | SH | | SOLE | | 1,416,530 | 0 | 0 |
Vincerx Pharma, Inc. | COM | 92731L106 | 966 | 241,379 | SH | | SOLE | | 241,379 | 0 | 0 |
Xenon Pharmaceuticals Inc. | COM | 98420N105 | 22,978 | 751,639 | SH | | SOLE | | 751,639 | 0 | 0 |
Zymeworks Inc. | COM | 98985W102 | 11,190 | 1,708,472 | SH | | SOLE | | 1,708,472 | 0 | 0 |
Insmed Incorporated | Note 0.75% 6/1/2028 | 457669AB5 | 38,614 | 40,000,000 | PRN | | SOLE | | 40,000,000 | 0 | 0 |
Invitae Corporation | Note 2.0% 9/1/2024 | 46185LAB9 | 8,379 | 10,300,000 | PRN | | SOLE | | 10,300,000 | 0 | 0 |
Sarepta Therapeutics, Inc. | DBCV 1.5% 11/15/2024 | 803607AB6 | 38,359 | 29,174,000 | PRN | | SOLE | | 29,174,000 | 0 | 0 |